Question 1

What is Insmed's P/B ratio?

Accepted Answer

Insmed (INSM) P/B ratio is 28.8× as of June 5, 2026. The ratio is calculated by dividing market capitalisation by book value of equity, using USD-normalised financials (IAS 21 exchange-rate translation for non-USD reporters).

Question 2

How is the P/B ratio calculated?

Accepted Answer

P/B = Market Capitalisation ÷ Book Value of Equity (most recent quarterly shareholders' equity), or equivalently Share Price ÷ Book Value Per Share. All inputs are sourced from audited GAAP/IFRS filings and translated to USD using period-end exchange rates so the multiple is comparable across companies and currencies.

Question 3

What is the P/B ratio?

Accepted Answer

The price-to-book (P/B) ratio compares a company's market capitalisation to its book value of equity (total shareholders' equity) on the most recent quarterly balance sheet. It is calculated as market cap ÷ book value of equity (equivalent to share price ÷ book value per share). A P/B below 1× implies the market values the business below its accounting net worth; values well above 1× reflect intangible assets, brand value, or a high return on equity.

Question 4

What is a good P/B ratio for Insmed?

Accepted Answer

A "good" P/B depends on the business model. Banks, insurers, and other capital-heavy financials typically trade near 1×; asset-light technology and consumer-brand companies can sustainably trade at 5×+ because much of their value is intangible. P/B is most informative when paired with return on equity (ROE). For Insmed specifically, the relevant sector benchmark is the current sector median of 3.4×.

Question 5

Is Insmed's P/B ratio high or low?

Accepted Answer

Insmed's P/B ratio of 28.8× is below its own 5-year average of 53.4× and above the sector median of 3.4×. That places the current reading at the 53th percentile of its 10-year history. A higher multiple usually reflects stronger expected growth, lower perceived risk, or higher returns on capital; a lower multiple reflects the opposite.

Question 6

What is Insmed's historical P/B ratio range?

Accepted Answer

In the available daily series, Insmed (INSM) P/B ratio has ranged from a low of 0.3× in 2002 to a high of 314.9× in 2024. The 5-year average is 53.4× and the 5-year median is 31.2×.

Question 7

What was Insmed's P/B ratio in 2025?

Accepted Answer

Insmed (INSM) P/B ratio at the end of 2025 was 50.3×. Annual values reflect the multiple on the last trading day of each calendar year, using the trailing twelve-month book value figure available at that date.

Question 8

Why does Insmed's P/B ratio change over time?

Accepted Answer

Valuation multiples move with two inputs: the numerator (market capitalisation, which tracks the share price) and the denominator (book value). Share-price changes — driven by interest rates, earnings expectations, risk appetite, and broader market sentiment — typically dominate short-term moves, while changes in the underlying fundamental drive the longer-term trend. As a result, the ratio can rise during stock-price rallies even if the business itself has not become more valuable, and fall during sell-offs even when fundamentals are improving.


2025	$37.18B	$738.98M	50.3×	+7.0×	Dec 31, 2025
2024	$12.36B	$285.38M	43.3×	—	Dec 31, 2024
2023	$4.49B	−$331.92M	—	—	Dec 31, 2023
2022	$2.65B	$87.95M	30.1×	+22.3×	Dec 31, 2022
2021	$3.23B	$410.47M	7.9×	-4.5×	Dec 31, 2021
2020	$3.41B	$275.88M	12.3×	+4.2×	Dec 31, 2020
2019	$2.13B	$261.67M	8.2×	+3.3×	Dec 31, 2019
2018	$1.01B	$208.27M	4.8×	-1.8×	Dec 31, 2018
2017	$2.39B	$361.06M	6.6×	+1.3×	Dec 31, 2017
2016	$815.67M	$154.48M	5.3×	+1.7×	Dec 31, 2016
2015	$1.11B	$311.70M	3.6×	-0.5×	Dec 31, 2015
2014	$754.39M	$186.24M	4.1×	-0.6×	Dec 31, 2014
2013	$666.21M	$143.32M	4.6×	+2.9×	Dec 31, 2013
2012	$210.28M	$120.88M	1.7×	+1.2×	Dec 31, 2012
2011	$75.79M	$134.27M	0.6×	-0.1×	Dec 31, 2011
2010	$118.68M	$192.84M	0.6×	-0.2×	Dec 31, 2010
2009	$100.26M	$123.91M	0.8×	—	Dec 31, 2009
2008	$57.18M	−$2.82M	—	—	Dec 31, 2008
2007	$100.56M	$11.49M	8.8×	+2.4×	Dec 31, 2007
2006	$88.61M	$13.88M	6.4×	-8.6×	Dec 31, 2006
2005	$157.57M	$10.53M	15.0×	+1.3×	Dec 31, 2005
2004	$98.92M	$7.24M	13.7×	+9.3×	Dec 31, 2004
2003	$114.03M	$26.22M	4.3×	+3.7×	Dec 31, 2003
2002	$14.58M	$23.45M	0.6×	-1.5×	Dec 31, 2002
2001	$125.75M	$59.70M	2.1×	—	Dec 31, 2001


Quest Diagnostics (DGX)	2.9×
Moderna (MRNA)	2.7×
Charles River (CRL)	2.6×
Regeneron Pharmaceuticals (REGN)	2.6×
Henry Schein (HSIC)	2.5×
Labcorp Holdings (LH)	2.5×
Danaher (DHR)	2.4×
UnitedHealth Group (UNH)	2.4×
Solventum (SOLV)	2.3×
Becton, Dickinson and (BDX)	1.8×
Pfizer (PFE)	1.8×
Molina Healthcare (MOH)	1.7×
Cigna (CI)	1.7×
Waters Corporation (WAT)	1.6×
Cooper Companies (COO)	1.5×
Elevance Health (ELV)	1.5×
Universal Health Services (UHS)	1.5×
Biogen (BIIB)	1.4×
Baxter International (BAX)	1.4×
Revvity (RVTY)	1.4×
Zimmer Biomet Holdings (ZBH)	1.2×
CVS Health (CVS)	1.2×
Humana (HUM)	1.1×
Viatris (VTRS)	1.1×
Centene (CNC)	0.8×

P/B Ratio for Insmed (INSM)

P/B Ratio daily chart for Insmed (INSM)

Historical P/B Ratio for Insmed (INSM) from 2001 to 2025

About P/B Ratio at Insmed (INSM)

Insmed P/B Ratio by Year

Insmed P/B Ratio 2025: 50.3×

Insmed P/B Ratio 2024: 43.3×

Insmed P/B Ratio 2022: 30.1×

Insmed P/B Ratio 2021: 7.9×

Insmed P/B Ratio 2020: 12.3×

Sector peers by P/B Ratio — chart

Sector peers by P/B Ratio — table

Frequently asked questions

Insmed (INSM) Key Financials

P/B Ratio daily chart for Insmed (INSM)

Historical P/B Ratio for Insmed (INSM) from 2001 to 2025

About P/B Ratio at Insmed (INSM)

Insmed P/B Ratio by Year

Insmed P/B Ratio 2025: 50.3×

Insmed P/B Ratio 2024: 43.3×

Insmed P/B Ratio 2022: 30.1×

Insmed P/B Ratio 2021: 7.9×

Insmed P/B Ratio 2020: 12.3×

Sector peers by P/B Ratio — chart

Sector peers by P/B Ratio — table

Frequently asked questions

+What is Insmed's P/B ratio?

+How is the P/B ratio calculated?

+What is the P/B ratio?

+What is a good P/B ratio for Insmed?

+Is Insmed's P/B ratio high or low?

+What is Insmed's historical P/B ratio range?

+What was Insmed's P/B ratio in 2025?

+Why does Insmed's P/B ratio change over time?

Insmed (INSM) Key Financials